Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Jacques PF, Hartz SC, Chylack LT Jr, et al
It is not a medical instruction nor a recommendation for dosing in humans
The fusion product is resistant to DPP-4 degradation, due to an alanine to glycine substitution at position 2 (A2G) in each of the peptide sequences 28,29 , and has a plasma half-life of five days on average in humans 30,31,32
Combining GHK-Cu with BPC-157 in the same injection reportedly reduces discomfort as well
Oral troche (daily or as prescribed) Injection (clinician-guided schedule) Starting at $187/mo Starting at $224/mo *Individual results vary
US$ 24.68
US$ 24.41
US$ 21.30
US$ 26.59
